Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled nitric oxide

W M Zapol1

  • 1Massachusetts General Hospital, Boston 02114, USA.

Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Inhaling low levels of nitric oxide (NO) impacts lung function and blood flow. This review covers NO therapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Intensive care medicine·2014
Same author

Breathing pattern, CO2 elimination and the absence of exhaled NO in freely diving Weddell seals.

Respiratory physiology & neurobiology·2008
Same author

Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.

Circulation·2001
Same author

Acute cor pulmonale in acute respiratory distress syndrome: a dreaded complication of the past?

Critical care medicine·2001
Same author

Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.

Journal of the American College of Cardiology·2001
Same author

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension.

Critical care medicine·2001
Same journal

Abstracts from the Scandinavian Society of Anaesthesiologists, 30th Congress, 10-13 June 2009, Odense, Denmark.

Acta anaesthesiologica Scandinavica. Supplementum·2009
Same journal

Abstracts from the 29th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, 5-8 September 2007, Goteborg, Sweden.

Acta anaesthesiologica Scandinavica. Supplementum·2007
Same journal

Abstracts from the 28th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Reykjavik, Iceland.

Acta anaesthesiologica Scandinavica. Supplementum·2005
Same journal

Abstracts from the 27th Congress of The Scandinavian Society of Anaesthesiology and Intensive Care Medicine. August 16-20, 2003, Helsinki, Finland.

Acta anaesthesiologica Scandinavica. Supplementum·2003
Same journal

Abstracts from the 26th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. June 13-17, 2001. Tromso, Norway.

Acta anaesthesiologica Scandinavica. Supplementum·2001
Same journal

The Scandinavian Society of Anaesthesiologists 25th Congress. Aarhus, Denmark, June 9-11, 1999. Abstracts.

Acta anaesthesiologica Scandinavica. Supplementum·1999
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Cardiovascular Physiology
  • Medical Biochemistry

Background:

  • Nitric oxide (NO) plays a crucial role in regulating vascular tone and gas exchange.
  • The NO-guanylate cyclase signal transduction pathway is critical for NO's physiological effects.
  • Recent advancements have spurred clinical interest in inhaled NO therapy.

Purpose of the Study:

  • To elucidate the effects of inhaled nitric oxide (NO) on hemodynamic and gas exchange functions in healthy and diseased lungs.
  • To provide a comprehensive overview of the safety and potential hazards associated with inhaled NO therapy.
  • To focus on the clinical applications of NO in specific pulmonary conditions.

Main Methods:

  • Review of existing literature on inhaled NO therapy.

Related Experiment Videos

  • Analysis of studies investigating NO's impact on pulmonary hemodynamics.
  • Examination of clinical trial data concerning NO in lung diseases.

    • Main Results:

    • Inhaled NO selectively reduces pulmonary artery pressure and improves oxygenation in various lung diseases.
    • NO administration can lead to adverse effects, necessitating careful monitoring.
    • The NO-guanylate cyclase pathway is a key target for NO's therapeutic actions.

    Conclusions:

    • Inhaled NO is a promising therapeutic agent for conditions like pulmonary hypertension and ARDS.
    • Understanding NO's mechanisms and safety profile is crucial for effective clinical use.
    • Further research is warranted to optimize NO therapy and explore new applications.